Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Return on Equity (2018 - 2025)

Crinetics Pharmaceuticals has reported Return on Equity over the past 8 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Equity for Q4 2025 was 0.0% at Crinetics Pharmaceuticals, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q1 2025 and troughed at 0.01% in Q2 2023.
  • A 5-year average of 0.0% and a median of 0.0% in 2022 define the central range for Return on Equity.
  • On a YoY basis, Return on Equity climbed as much as 0bps in 2021 and fell as far as 0bps in 2021.
  • Year by year, Return on Equity stood at 0.0% in 2021, then dropped by -20bps to 0.0% in 2022, then rose by 21bps to 0.0% in 2023, then rose by 28bps to 0.0% in 2024, then plummeted by -63bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for CRNX at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.